Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.620NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
V.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.10 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.41 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.142NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.11 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.250NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.8 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.90 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used